مواقع التدريسيينجامعة الكوفة
AMMAR ABDUL AZEEZ ABDUL SAHIB ALIBEK
Assistant Professor

AMMAR ABDUL AZEEZ ABDUL SAHIB ALIBEK

0Publications
0Lectures
0Interests

About

-B.Sc.in science of pharmacy from faculty of pharmacy-Kufa University in 2006, -Training Pharmacist in AL Zahraa teaching hospital for 2007. -Researcher pharmacist in Faculty of pharmacy- University of kufa for 2010. -M.Sc. in pharmaceutical Chemistry from College of pharmacy-Baghdad University in 2013, PhD in pharmaceutical chemistry from college of pharmacy-Baghda University in 2023-Now ,Assistant Professor doctor in Faculty of pharmacy- University of kufa

Research Interests

1

Publications

14
2021

Exacerbation of COVID 19 in Hypertensive Patients

AuthorsNoor H. Naser, Ammar Abdul Aziz Alibeg
JournalIraqi J Pharm Sci
Abstract

Abstract Since its discovery in December 2019, corona virus was outbreak worldwide with a very rapid rate, so it described by World Health Organization (WHO) as a pandemic. It associated with severe acute respiratory distress syndrome, and can invade the cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important role as regulator for blood pressure. Hypertension is a potential risk factor for sever acute respiratory syndrome COVID-19, and associated with high mortality rate as shown in many epidemiological studies. A lot of published article reviews, retrospective and meta-analysis regard the association between COVID-19 and hypertension. Moreover, specific antihypertensive medications that infected patients were receiving are not known; only data about renin-angiotensin-aldosterone system (RAAS) are available. Objective: To summarize the most updated data of COVID-19 in hypertensive patients. Keywords: COVID-19, hypertension, Angiotensin Converting Enzyme 2 (ACE2)

2021

Evaluation of the Mixture of phoenix Dactylifera Seeds extract and Chalcone Derivativeas Anti-Angiogenic Agents in Ex-Vivo Rat Aorta Ring Model

AuthorsSamer Ali Hasan1, Ammar Abdul Aziz Alibeg2, Zeena Ayad Hussein3
JournalAnnals of R.S.C.B
Abstract

Abstract: Angiogenesis is very important in the progression of various pathological disorders, most importantly tumor growth and metastasis. This research aims to investigate the efficacy of the synthetic chalcone derivative)2-Hydroxychalcone)and its mixture with ethanolic extract of Phoenix dactylifera seeds as anti-angiogenic agents. The synthetic chalcone derivative was synthesized according to Claisen-Schmidt condensation method using SOCl2/ETOH as a catalyst with a good yield. The structure of the synthesizedchalcone derivative has been characterized by TLC, melting point, UV, and IR Spectroscopy , and elemental microanalysis (CHNO). The powdered seeds of P. dactylifera were extracted by soxhlet extraction with Ethanol. The synthetic chalcone derivative alone at concentration (17.15μg/ml) and its mixture with ethanolicextract of P. dactylifera seeds were evaluated for its anti-angiogenic activity using the ex-vivo rat aorta ring model at concentrations 17.15μg/ml and 30.9μg/ml respectively. At the previously mentioned concentrations, The synthetic chalcone derivativewas able to inhibit growth of blood vessels significantly (56.23%) in rat aorta ring assay in comparison with the negative control (P<0.05), while the mixture of the synthetic chalcone derivative and ethanolic extract of P. dactylifera seeds showed higher percentage of inhibition (76.63%)than that of the synthetic chalcone derivative alone in comparison with the negative control (P<0.05).Thisproduced effect could be due to the synergism between the synthetic chalcone derivative and the phytochemical constituents present in ethanolic extract in inhibiting different angiogenesis signaling pathways.

2020

Design, Synthesis, and Antibacterial Study of New Gatifloxacin-Antioxidants as Mutual Prodrugs

AuthorsNoor H. Nasser, Sahar A. Hussein, Ahmed K. Hussein, Ammar A. Alibeg, and Zainab M. Jasim
JournalJ Biochem Tech
Abstract

Abstract Objective: The objective of this search is to design, and synthesize new mutual prodrugs in order to obtain synergistic antibacterial activity. Methods: The hydroxyl group of three antioxidants (menthol, thymol, and vanillin), was linked to chloroacetyl chloride through nucleophilic substitution reaction, to give intermediates (Ia-Ic), which were reacted with a carboxyl group of Gatifloxacin to form three final compounds (I-III) having ester linkage. Results: The Antibacterial activity effect of the target compounds (I-III) has been tested for in vitro inhibitory activity against Gram-positive bacteria: Staphylococcus aureus and Gram-negative bacteria: Escherichia coli by using spots diffusion method. All the tested compounds show a remarkable antibacterial activity against tested bacteria. Conclusion: The synthesized prodrugs were characterized and identified through FT-IR spectroscopy, 1H-NMR spectrum, and various physicochemical parameters. The antibacterial study of the compounds showed various activities toward the two types of pathogenic bacteria which are Staphylococcus aureus and Escherichia coli. Compounds [I, II, and III] revealed that Staphylococcus aureus was sensitive to synthesized compounds but Escherichia coli showed a reverse activity with some resistance for antibacterial drugs .

2020

Design and Synthesis of Possible Mutual Prodrugs of (Nsaid) Etodolac and Tolmetin with (Cytotoxic) Gemcitabine

AuthorsAmmar Abdul Aziz Alibeg1, Abbas H. Abdulsada2, Noor H. Nasser3, Karrar Abdil Aziz Ali beg4
JournalSys Rev Pharm
Abstract

ABSTRACT [NSAIDs] Non-steroidal anti-inflammatory drugs consider an important group of drugs due to their properties as anti-inflammatory and it have both antipyretic and pain killer activities. [COX-II] plays an important role all over oncogenesis and here we attempt the same thing to search the use of [NSAID] (Etodolac & tolmetin) in conjugation with current cytotoxic agent (Gemcitabine) for the prevention and/or management of cancer. This study distinguishes the designing and synthesis of mutual prodrug of [NSAID] & gemcitabine, which is specified to create the concomitantly pharmacological action as a one chemical entity with amend of targeting of drug. The synthesized compound was conferred by TLC, CHNS, FTIR and physicochemical properties. The newly synthesized prodrug is predicted to reduce the adverse effects of [NSAIDs] on the (GIT) gastrointestinal tract with enhancement of gemcitabine oral bioavailability and its targeting.

2020

Design, Synthesis and Preliminary Pharmacological Evaluation of Mutual Prodrug of Non Steroidal Anti-Inflammatory Drugs Coupling with Natural Anti-Oxidants

AuthorsAMMAR ABDUL AZIZ ALIBEG1, SAMER A. HASAN2, AHMAD K. HUSSEIN3, NOOR H. NASSER4, KARRAR ABDIL AZIZ ALIBEG
JournalInternational Journal of Pharmaceutical Research
Abstract

ABSTRACT Non steroidalanti inflammatory drugs NSAIDs Etodolac and tolmetin drugs have been coupled with varies natural antioxidants having antiulcerogenicpropertiesin order to get mutual prodrug consist of NSAIDs & antioxidant as a safer NSAIDs withoutgastrointestinal side-effects. The designated pro-drugs are well studied to explain their anti inflammatory, anti ulcer and analgesic activity. The mutual prodrug shows the same activity as anti inflammatory with decrease ulcerogenecity. The study results show that the mutual prodrug of NSAIDs antioxidant has the strength to create new NSAIDs with decreased undesirable adverse effects.

2018

Design and Synthesis of Possible Mutual Prodrugs of Naproxen and Acetylsalicylic Acid with Gemcitabine

AuthorsAmmar Abdul Aziz Alibeg
JournalJournal of Applicable Chemistry
Abstract

ABSTRACT ‘Non-steroidal anti-inflammatory’ (NSAIDs) drugs are most commonly used type of medications and its long period of use result in unwanted side effect like (GI) ulceration. (COX-II) have an important role all over oncogenesis and so I explain the cause of using (NSAID) (naproxen and Acetylsalicylic acid) together with cytotoxic drug [Gemcitabine] in the management of cancer. The research outlines the designing and synthesis of mutual prodrug of (NSAID) and (gemcitabine), which is nominated to create the interdependent pharmacological action as a single pharmacological unit with enhanced drug targeting. The synthesized products was advised by (FTIR) chart, (CHNS) analysis and physiochemical properties. The synthesized prodrug is supposed to diminish the undesirable effect of (NSAIDs) on the (GI) tract with amendment of the bioavailability and cancer targeting for (gemcitabine).

2018

Synthesis of Mutual Pro-drugs through coupling of Etodolac And Tolmetin by Sulfa drugs

AuthorsAmmar Abdul Aziz Alibeg
JournalAMERICAN JOURNAL OF PHARMATECH RESEARCH
Abstract

ABSTRACT [NSAIDs] “non-steroidal anti-inflammatory drugs” always enter in the management of chronic diseases associated with inflammation, but it have many unwanted side effects, one of them is stomach irritation and ulceration. The Co-drug approach is a strategy used to solve this problem. The mutual Pro-drug composed of two therapeutically active materials coupled to each other via covalent bond. Because of the infection always lead to inflammation. So [NSAID] could be coupled with sulfa drugs together as single drug via amide linkage. Here the carrier molecules “sulfonamides” could be helpful to counteract part of side effects of prime drug especially (GI) ulceration. By this work I wish to explain the procedure that I used in coupling of Etodolac and Tolmetin with different sulfa drugs to create amide containing products. Therefor the synthesized products could be useful in the management of infection and inflammations.

2015

DESIGN AND SYNTHESIS OF NEW DERIVATIVES OF KETOPROFEN LINKED TO NATURAL ANTIOXIDANTS (THYMOL, MENTHOL & GUAIACOL) AS POSSIBLE MUTUAL PRODRUGS

AuthorsAhmed Kareem Hussein Mubarak, Dhurgham Q. Shaheed , Ammar Abdul Aziz libeg, Hayder Kadhium Abbas, Mohammed Dakhil ALRekabi, Ahmed Hashim Husssein اسماء المساعدين:
JournalWorld Journal of Pharmaceutical Research india
Abstract

bstract Non-steroidal anti-inflammatory drugs (NSAIDs) represent one of the most widely used classes of drugs. They are used primarily for the treatment of osteoarthritis, rheumatoid arthritis and other inflammatory disorders. However, the use of NSAIDs is limited due to possibility of inducing erosions and ulcers in the gastrointestinal tract. Recently, it has been well established that generation of various reactive oxygen species (ROS) locally plays a significant role in the formation of gastric ulceration associated with NSAID therapy. Therefore, in the present study NSAIDs (ketoprofen) have been conjugated with different antioxidants (thymol, menthol and guaiacol) having anti ulcerogenic activity. The objective was to obtain Ketoprfen– antioxidant derivatives as possible mutual prodrug that includes: Ketoprofen-thymol (Compound I), Ketoprofen-menthol (Compound II) and Ketoprofen-guaiacol (Compound III). The mutual prodrug of NSAID and antioxidant was designated to generate the complementary pharmacological action as a single chemical entity with improved anti-inflammatory action and reduced ulcerogenic adverse effect. The synthesis is conferred by FT-IR, CHNS and physiochemical properties.

2014

Synthesis and Antimicrobial Study of Possible Mutual Prodrugs of Amoxicillin and Metronidazole by Direct and Indirect Coupling through Spacer

AuthorsAMMAR A. ALIBEG, Ahlam J. Qasir
JournalIraqi Journal of Pharmaceutical Sciences
Abstract

Abstract Amoxicillin have been conjugated with metronidazole as possible mutual prodrug to get a wider spectrum of activity by acting on aerobic and anaerobic bacteria, have antifungal activity, to provide protection for beta lactam ring of amoxicillin and also to improve patient compliance as it given as a single dose therapy. The structures of the synthesized compound were confirmed and characterized using elemental microanalysis (CHN), IR and some physiochemical properties. Biological study was done by using disc diffusion method against different bacterial strains which are , Staphylococcus aureus , Salmonella typhie , Pseudomonas aeruginosa , E. coli , Klebsiella pneumonia and fungi ( Candida albicans) . using nutrient agar medium and 5 mm diameter paper discs. The synthesized compounds showed maintenance or improvement of the antimicrobial activity especially compound (II) showed superior activity in comparison with compounds (I, III) . في هذا البحث نقوم بربط عقار الاموكسيسيلين مع عقار المترونيدازول كمقدمات دوائية لكي نحصل على فعالية ذات طيف أوسع من خلال عمله على البكتريا الهوائية و اللاهوائية , لديه فعالية ضد الفطريات , توفير حماية لحلقة البيتا لاكتام في الاموكسيسيلين و لتحسين استساغة المريض للعلاج . تم تشخيص المركبات المصنعة باستخدام التحليل الدقيق للعناصر المكونة لها و من خلال الأشعة تحت الحمراء و بعض الخواص الفيزيائية والكيميائية . دراسة الفعالية الحيوية تمت باستخدام طريقة الانبعاث القرصي ضد بعض سلالات البكتريا المختلفة و الفطريات و التي هي Staphylococcus aureus , Salmonella typhie , Pseudomonas aeruginosa , E. coli , Klebsiella pneumonia and Candida albicans . باستخدام وسط مغذي و أقراص ورقية قطر 5 مل . لقد أظهرت المركبات المصنعة تحسنا أو حفاظا على الفعالية المضادة للميكروبات وخصوصا المركب (II) حيث اظهر فعالية عالية مقارنة بالمركبات (I,III) .

SYNTHESIS AND BIOLOGICAL EVALUATION OF SOME NEWLY SYNTHESIZED SCHIFF BASE DERIVED QUINAZOLINONE AND CINNAMALDEHYDE

AuthorsAbbas H. Abdulsada, Ammar Abdul Aziz Alibeg2 , Ali N. Wannas3
JournalJOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS
Abstract

The goal of this research is to synthesize novel Schiff base-derived quinazolinone derivatives (4a and 4b) with improved antibacterial activities. Chemical procedures and spectrophotometric (IR and NMR) techniques were used to study and describe the produced compounds. Antibacterial screening tests for the target compounds were implemented against two gram-positive strains (Staphylococcus aureus, Staphylococcus faecalis) and two gram-negative strains (Escherichia coli, salmonella typhi) by scaling the diameter of the zone of bacterial inhibition. The results of these tests indicate that the synthesized Schiff bases exhibit an accepted level of biological activity against these microorganisms

Molecular Docking, Synthesis, Characterization, and Preliminary Cytotoxic Study of Novel 1, 2, 3-Triazole-Linked Metronidazole Derivatives

AuthorsHaider Hassan Alsayad , Ammar Abul Aziz Alibeg , Zeyad Kadhim Rad Oleiwi
JournalAdvanced Journal of Chemistry, Section A
Abstract

In this study, five novel 1,2,3-triazole derivatives linked to metronidazole that target EGRR TK in a non-small cell lung tumor were developed. The reaction of metronidazole propargylic ether derivative as terminal alkyne and aryl azide derivatives in the existence of sodium ascorbate and CuSO4.5H2O leads to the synthesis of desirable hybrid molecules (I-V) with anticancer properties. This method is recognized as the Cu-catalyst azide-alkyne cycloaddition. The software for MOE, edition 2015-10, was used for docking experiments, and for predicting cytotoxic activity, the MTT cell viability assay was employed. Both in vitro and docking studies revealed that the recently created substances have significant antitumor efficacy. In contrast to erlotinib, they demonstrated significant differences in potency. Compounds I–V all exhibit IC50 values between 3.2-12.677 μM against the cancer cell line A549 (a non-small lung tumor cell line). Compounds II, III, and IV showed moderate inhibitory activity, whereas Compounds I and V showed the highest inhibitory impact, with 3.21 and 4.1 μM, respectively, as the IC50 values. Based on docking and cytotoxic experiments, compounds I and V were shown to have the strongest inhibitory impact and improved binding energy. They contain biphenyl and benzene sulfonamide, respectively, which are connected to the 1, 2, 3-triazole ring in the para position. This suggests that they are the most promising candidates for use as anticancer medications. The recently synthesized compounds showed cytotoxicity and EGFR tyrosine kinase inhibitory potencies.

Molecular docking, synthesis, characteristics and preliminary cytotoxic study of new coumarin-sulfonamide derivatives as histone deacetylase inhibitors

AuthorsAmmar Abdul Aziz Alibeg, Mohammed Hassan Mohammed
JournalWiadomości Lekarskie Medical Advances
Abstract

Wiadomości Lekarskie” is an official journal of the Polish Medical Association published since 1928. The articles published in the monthly include original papers, review papers and case studies.

Design, Synthesis, Insilco Study and Biological Evaluation of New Isatin-Sulfonamide derivatives by using mono amide linker as possible as Histone Deacetylase Inhibitors

AuthorsAmmar Abdul Aziz Alibeg, Mohammed Hassan Mohammed
JournalPolski Merkuriusz Lekarski
Abstract

aim: To evaluate the cytotoxic activity of newly synthesized a series of novel HDAC inhibitors comprising sulfonamide as zinc binding group and Isatin derivatives as cap group joined by mono amide linker as required to act as HDAC inhibitors. Materials and Methods: The utilization of sulfonamide as zinc binding group joined by N-alkylation reaction with ethyl-bromo hexanoate as linker group that joined by amide reaction with Isatin derivatives as cap groups which known to possess antitumor activity in the designed of new histone deacetylase inhibitors and using the docking and MTT assay to evaluate the compounds. results: Four compounds have been synthesized and characterized successfully by ART-FTIR, NMR and ESI-Ms. the compounds were synthesized and characterized by successfully by ART-FTIR, NMR and ESI- Ms. Assessed for their cytotoxic activity against human colon adenocarcinoma MCF-7 (IC50, I=105.15, II=60.00, III=54.11, IV=56.57, vorinostat=28.41) and hepatoblastoma HepG2 (IC50, I=63.91, II=135.18, III=118.85, IV=51.46, vorinostat=37.50). Most of them exhibited potent HDAC inhibitory activity and significant cytotoxicity. Conclusions: The synthesized compounds (I, II, III and IV) showed cytotoxicity toward MCF-7 and HepG2 cancer cell lines and their docking analysis provided a preliminary indication that they are viable [HDAC6] candidates.

Design, Synthesis, And Antibacterial Study Of New Gatifloxacin Conjugated With Guaiacol And Paracetamol Analogues As Mutual Prodrug

AuthorsAhmed Kareem Hussein Mubarak, Ammar A. Alibeg,Noor H. Naser and Sahar A. Hussein
JournalNat. Volatiles & Essent. Oils
Abstract

Objective:The objective of the work to design, and synthesize new mutual prodrugs of gatifloxacin to improve the therapeutic action as anti-microbial mainly as anti-bacterial to overcome the emergent anti-bacterial resistance of the gatifloxacin in first approach and to broaden the anti-bacterial spectrum secondly .In our study we choose the ligand (quaiacol and paracrtamol) to link via an ester bond with gatifloxacin by spacer arm chloroacetyl chloride. The quaiacol is a natural anti-oxidants with mark able anti-bacterial action ,while paracetamol is a centrally non -steroidal anti-inflammatory drugs (NSAIDs) ,the up-to-date studies of paracetamol referred to it hasa good anti-bacterial action. Design of the new analogous of gatifloxacin with quiaicol&paracetamol respectively with complementary anti-bacterial action to synergize the therapeutic action and impair the microbial mechanism of resistance that is the major challenges of the most anti-bacterial antibiotic.Methods: The hydroxyl functional groupe of (quaiacol ,parcetamol), was conjugated to chloroacetyl chloride via a nucleophilic substitution profile reaction respectively, to produce an intermediates (IA-IB), which were further reacted with a carboxyl functional group of Gatifloxacin to produce the designed compounds (I-II) having an ester linkage as mutual prodrug.Results: The Antibacterial activity effect of the designed compounds (I-II) has been investigated for in vitro inhibitory anti-bacterial action against Gram-(+) bacteria like Staphylococcus aureus and Escherichia coli as Gram-negative bacteria; using the diffusion of the spots procedure. All the tested compounds show a remarkable antibacterial activity toward the tested bacteria.Conclusion:The synthesized designated mutual prodrugs were synthesized ,characterized and identified by using FT-IR spectroscopic analysis, 1H-NMR spectroscopic analysis, and important physicochemical properties. The antibacterial assay of the designated compounds report different activities toward the two types of pathogenic bacteria which are Staphylococcus aureus and Escherichia coli. Compounds [I, II] revealed that Staphylococcus aureus was sensitive to synthesized designated compounds but Escherichia coli report a reverse activity with some resistance for antibacterial drugs .

Lectures

5

antiviral

Organic Pharmaceutical Chemistry III

antineoplastic - alkylating agent

Organic Pharmaceutical Chemistry III

antineoplastic - antimetabolite

Organic Pharmaceutical Chemistry III

assay of borax

Organic Pharmaceutical Chemistry III

Drugs metabolism

Organic Pharmaceutical Chemistry I

View details